Heart drug for kids under safety watch
NCT ID NCT06659393
Summary
This study aims to monitor the safety of the heart medication Entresto in children aged 1 to 18 with chronic heart failure. It will follow 33 children in Japan for up to one year after they start taking the drug in their regular doctor's care. The main goal is to check for side effects like low blood pressure, high potassium, and kidney problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC CHRONIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGŌbu, Aichi-ken, 474 8710, Japan
-
Novartis Investigative Site
RECRUITINGToyoake, Aichi-ken, 470 1192, Japan
-
Novartis Investigative Site
RECRUITINGFukuoka, Fukuoka, 812-8582, Japan
-
Novartis Investigative Site
RECRUITINGKurume, Fukuoka, 830-0011, Japan
-
Novartis Investigative Site
RECRUITINGKurume, Fukuoka, 830-8543, Japan
-
Novartis Investigative Site
RECRUITINGSapporo, Hokkaido, 060 8648, Japan
-
Novartis Investigative Site
RECRUITINGTsukuba, Ibaraki, 305-8576, Japan
-
Novartis Investigative Site
RECRUITINGKawasaki, Kanagawa, 216-8511, Japan
-
Novartis Investigative Site
RECRUITINGYokohama, Kanagawa, 236-0004, Japan
-
Novartis Investigative Site
RECRUITINGTsu, Mie-ken, 514-8507, Japan
-
Novartis Investigative Site
RECRUITINGNagasaki, Nagasaki, 852-8501, Japan
-
Novartis Investigative Site
RECRUITINGŌmura, Nagasaki, 856-8562, Japan
-
Novartis Investigative Site
RECRUITINGOkayama, Okayama-ken, 700-8558, Japan
-
Novartis Investigative Site
RECRUITINGHidaka, Saitama, 350-1298, Japan
-
Novartis Investigative Site
RECRUITINGSaitama, Saitama, 330 8777, Japan
-
Novartis Investigative Site
RECRUITINGHamamatsu, Shizuoka, 430-8558, Japan
-
Novartis Investigative Site
RECRUITINGBunkyo Ku, Tokyo, 113 8655, Japan
-
Novartis Investigative Site
RECRUITINGBunkyo Ku, Tokyo, 113-8431, Japan
-
Novartis Investigative Site
RECRUITINGBunkyo-ku, Tokyo, 113-8603, Japan
-
Novartis Investigative Site
RECRUITINGFuchū, Tokyo, 183-0003, Japan
-
Novartis Investigative Site
RECRUITINGFuchū, Tokyo, 183-8561, Japan
-
Novartis Investigative Site
RECRUITINGŌta-ku, Tokyo, 143 8541, Japan
-
Novartis Investigative Site
RECRUITINGSetagaya-ku, Tokyo, 157-8535, Japan
-
Novartis Investigative Site
RECRUITINGShinagawa-ku, Tokyo, 142-8666, Japan
-
Novartis Investigative Site
RECRUITINGShinjuku Ku, Tokyo, 162 8666, Japan
-
Novartis Investigative Site
RECRUITINGToyama, Toyama, 930-0194, Japan
-
Novartis Investigative Site
RECRUITINGAkita, 010-8543, Japan
-
Novartis Investigative Site
RECRUITINGKumamoto, 862-8505, Japan
Conditions
Explore the condition pages connected to this study.